RE: FDA approval of Rebyota bodes well5 Dec 2022 22:56
Candid, it's fair to say Equity Development have kept their view on "Fair Value" for a very long time, notwithstanding they have had plenty of opportunity to reduce it. Are they right? Time will tell. Where they definitely are right is that the value of the assets of this company have gone up not down, notwithstanding the slide in the share price which merely reflects current investor sentiment and not the asset. Hence as we know it could leap very quickly and it is quite possible that ultimately the sp is significantly more than the fair value, but that is merely dreaming. I am happy to look at the fair value. The really good news is that things could happen here very quickly, not years down the line. I have increased my holding here recently by 50%. at very little cost, pro rata to fair value.